Dr. Vince Clinical Research is a trusted contract research organization (CRO) for human abuse potential (HAP) trials. We understand the importance of early and consistent engagement with the FDA’s Controlled Substances Staff (CSS) to maintain regulatory compliance and alignment with FDA expectations. Our proficiency in working with Controlled Substances Staff (CSS) ensures proper feedback is provided and addressed to reduce the risk of delays. These combined factors help bring safe medications to the market and enables us to efficiently conduct HAP trials.
This video is part 7 of our Human Abuse Potential Series. Join Naama Levy-Cooperman, Director at Altreos Research Partners, as she discusses aligning HAP studies with the FDA, engaging with CSS and the importance of study review. Stay tuned for additional videos in which we continue to showcase what makes DVCR experts in human abuse potential studies.
